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Oncoprotein c-Fos and c-Jun immunopositive cells and cell clusters in herniated intervertebral disc tissue Furthermore, transient inhibition of protein synthesis induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle [18] .
The proto-oncogene products c-Fos and c-Jun connect or heterodimerize through their leucine zippers to form the AP-1 transcription factor [15] . The transcriptional activity of the heterodimer is regulated by signal-dependent phosphorylation and dephosphorylation events.
In human chondrocytes, c-Fos and c-Jun genes are expressed both in normal and osteoarthritic articular cartilage [26] . Osaki et al. have demonstrated that in rat chondrocytes the cell growth inductive and the mitogenic effect of transforming growth factor β1 (TGF-β1) are mediated by the c-Fos gene [13] . In an experimental osteoarthritis (OA) model, oncoproteins were detected predominantly in the synovial lining cells [16] , whereas in normal synovial lining cells such reactivity was low. Furthermore, in OA cartilage chondrocytes at the superficial and middle layers were found to participate in the synthesis of oncoproteins [16] .
Overexpression of the c-Fos proto-oncogene has recently been shown to inhibit chondrocyte differentiation [21] . Interestingly, however, the rates of proliferation and apoptosis were unaffected. Nodule formation was inhibited if induction of c-Fos was only at early stages of differentiation [21] .
The level of expression of c-Jun is lower in maturing or hypertrophic chondrocytes than in proliferating chondrocytes [9] . This suggests that the c-Jun family negatively regulates the maturation process of chondrocytes.
Activation of AP-1, a heterodimeric complex of Fos and Jun proteins, is required for chondrocyte matrix metalloproteinase production and cell proliferation [10] . Cytokines and growth factors induce reactive oxygen species production, which is a signal pathway for activation of AP-1. In herniated disc tissue, matrix metalloproteinase activity is prevalent [17] , and there is a change in the balance between degradative enzymes and endogenous inhibitors.
Clusters of disc cells have been observed in degenerated intervertebral disc tissue [8] . Earlier studies have reported similar clusters of chondrocytes in osteoarthritic cartilage, where they have been linked to a possible production of extracellular matrix components involved in matrix repair [8] . In intervertebral disc tissue, such clusters could perhaps participate in the repair of tissue damage, but very little is so far known about such clusters of disc cells.
We analyzed the transcription promoters c-Fos and c-Jun in herniated disc tissue in order to locate potential cell transcription and cell activation, thereby identifying possible differences in oncoprotein expression between normal and herniated disc tissue. Previously there has been no research concerning oncoprotein expression in intervertebral disc tissue. These proteins are essential in the signal pathway from the cell membrane to the nucleus. Further knowledge regarding this signal pathway may bring forth new specific treatments for disc pathology.
Materials and methods
We analyzed tissue material from 38 discectomy operations. As a normal control we used nucleus pulposus material from a disc tissue bank (-70°C) of four organ donors, none of whom had any history of low back pain. The control tissue was obtained by an anterior approach. A detailed description of the clinical data of the disc tissue material from the herniated discs and normal controls is given in Table 1 . The preoperative pain duration was reported by the patients in a routine low-back pain patient questionnaire, including items on preoperative radicular pain duration, a pain drawing, the Oswestry Disability Index and patient demographics.
After removal, tissue material was immediately frozen to -70°C in the operating theater, and 8-µ-thick cryostat sections were fixed in ice-cold acetone. Immunoreactions were detected using an avidin biotin complex-(ABC-) peroxidase staining kit (Vectastain Elite, Vector Laboratories, Burlingame, Calif., USA). Hematoxylin was used for counterstaining.
We used monoclonal c-Fos and c-Jun antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, Calif., USA), both at the dilution 1:50. As a positive control we used rheumatoid arthritic synovia and human dermal skin samples. As a method control for monoclonal immunostaining, we also stained sections omitting the primary antibody. We also did immunostaining as above following preabsorption of the two monoclonal antibodies with the corresponding antigen at 1:10.
Three sections from each disc specimen were stained with both antibodies. The presence or absence of immunostaining was compared with clinical data (age, gender, preoperative pain duration and prolapse type).
Statistical analyses were done using the SOLO statistical software program (BMDP, Los Angeles, Calif., USA). Groups were compared using either chi-square analyses or Fisher's exact test, as applicable. Level of statistical significance was set at P<0.05. 
Results
The clinical data of herniated discs are shown in Table 1 . Herniated disc tissue samples were classified by the operating surgeon as previously described [20, 22] . Control discs showed a normal morphology macroscopically; no signs of autolysis were observed, i.e. all disc cells looked intact. All control discs were immunonegative for both c-Fos and c-Jun (Fig. 1a, Fig. 2b ). Rheumatoid arthritic synovia and dermal samples, studied as positive controls, showed c-Fos and c-Jun immunopositive cells. Sections stained omitting the primary antibody did not show any immunoreaction for either of the oncoproteins. Neither did sections preabsorbed with the corresponding antigen. Oncoprotein c-Fos immunoreaction was noted in 15/38 herniated samples (39%) (Fig. 1b,c) and for c-Jun in 28/38 (74%) (Fig. 2b,c ; Table 2 ). For each of these disc samples studied, when immunopositivity was detected, it was observed in all three sections cut through the respective specimen. When a disc sample was immunonegative, none of the three sections studied showed any immunoreactivity. Immunopositive clusters of disc cells (conglomerates, i.e., ≥3 cells) were seen in 25% of the total immunopositive samples (7/28) ( Table 2 ). The immunoreaction in these clusters of disc cells was mainly of the c-Jun type (Fig. 2b,c) .
None of the studied herniated discs showed immunoreactivity only to c-Fos. Immunoreactivity only to c-Jun was detected in 13 disc herniation samples and reactivity to both oncoproteins in 15 disc herniation samples (Table 2) .
Twenty-three of the herniated samples were from men and 15 from women. The age of the patients varied from 20 to 74 years (mean 41.6 years). Twenty-four of the her- niation samples were extruded, 12 sequestrated and 2 protruded. Detailed immunoreaction in different subgroups is shown in Table 3 and Table 4 . We did not note any gender-related differences in the immunoreactivity. Nor were there any statistically significant differences regarding proto-oncogene immunoreactions in extrusions compared to sequestrations ( Table 3 ). The total number of protrusions (n=2) was too small to make any statistical analysis.
Comparing the pain duration before operation, there were no statistically significant differences between the acute/subacute and chronic group regarding the immunoreaction for the proto-oncogenes c-Fos and c-Jun (Table 4) . Nor did the presence of immunoreaction in cell groups (conglomerates) show any statistical difference between these two groups ( Table 4) .
Discussion
Nuclear oncoproteins c-Fos and c-Jun (or its related proteins JunB or JunD) represent the transcription factor AP-1 (activating protein-1), and they may act as an intracellular messenger converting short-term signals generated by extracellular stimulators into long-term changes in cell phenotype. This is done by regulating the expression of downstream genes that possess an AP-1 binding site [1] .
The importance of AP-1 transcription factors in chondrocyte differentiation has been highlighted in an in vitro study by Thomas et al. [21] . In particular, their study found that the induction of c-Fos resulted in a concomitant increase in the expression of fra-1 and c-Jun. Furthermore, the overexpression of c-Fos was found to directly inhibit chondrocyte differentiation.
It has previously been shown that the growth-stimulative effect of transforming growth factor β1 in chondrocytes is mediated by the activation of the oncoprotein c-fos gene [13] . This is mediated by protein kinase activation [25] . In the present study, we show the expression of the oncoproteins c-Fos and c-Jun in herniated disc tissue. We have previously reported expression of TGF-β and induction of TGF-β receptor in these same tissues [23] . This may suggest that the proliferative effect of TGF-β is at least partly mediated by these oncoproteins in herniated disc tissue as well.
In rheumatoid cartilage, the matrix metalloproteinase-1 (MMP-1) promoter is demonstrated to be activated by Jun-related proteins as well as Fos/Jun-related protein heterocomplex [24] . Furthermore, c-Fos combined with any of the Jun-related proteins failed to stimulate the tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter, although it was activated by Jun-related protein heterocomplexes [24] . In the present study, we did not see c-Fos immunopositivity alone (Table 2) , whereas c-Jun immunoreactivity was noted as well as the immunoreactivity to both oncoproteins (Table 2 ). This may suggest that the proteolytic activity is controlled by the expression of the c-Fos and c-Jun oncoproteins in herniated disc tissue as well.
Interestingly, the oncoprotein expression in disc cell clusters was mainly of the c-Jun type. This may indicate that in disc cell clusters c-Jun may be more important than c-Fos. Turnover of the matrix components is established with an intricate balance between synthesis and degradation of the associated molecules, such as MMP and TIMP. c-Fos has been demonstrated to be degradative [24] , whereas Jun-related proteins stimulate both MMP and TIMP [24] . This may indicate that disc cell clusters participate in the turnover of extracellular matrix components. Marked degradative enzyme activity in disc tissue after disc herniation has been noted previously [12] . Furthermore, disc tissue has a tendency to decrease in size after herniation [11, 19] . Matrix metalloproteinase activation in herniated disc tissue has previously been shown [17] . There was a change in the balance between degradative enzymes (MMPs) and endogenous inhibitors (TIMPs) [17] . Regulation of this balance could be partly mediated by AP-1 protein in disc tissue as well.
The duration of pain before operation had no significant association with the expression of oncoproteins. The results did not show any statistical difference between acute/subacute and chronic herniations. Previously it has been shown by Paajanen and coworkers that the proliferation potential drops in recurrent herniations [14] . That study did not show any correlation between proliferative disc cells and the degree of disc degeneration on magnetic resonance imaging.
The formation of clusters of disc cells is associated with degenerative disc disease [8] . These clusters may produce certain extracellular matrix components and they may also function to repair damaged tissue. The pattern of proliferation cell nuclear antigen (PCNA) and proliferation-associated antigen Ki-67 positivity in degenerated disc tissue samples suggests that disc cell clusters arise through increased cell proliferation [8] . Furthermore, colony formation in vitro by annular intervertebral disc cells from patients with degenerative disc disease and young controls has previously been demonstrated [6] .
Conclusions
Taken together, our findings of oncoprotein c-Fos and c-Jun expression in disc cells and cell clusters may indicate that disc cells respond to disc herniation. This might mean that disc cells participate in a reaction cascade, where they are actively in contact with the surrounding tissue. This also implies that more information about disc cells will be required before we can better understand mechanisms of disc degeneration and herniation, and the tissue remodelling that follows upon a disc herniation. Furthermore, in the future, we believe that disc cell research regarding the signal pathway from the cell membrane to the nucleus will provide more information on how disc cells function in different stages of the cell cycle, and in different pathological conditions. Pathological conditions of interest include disc degeneration and disc herniation. This may provide us with new types of treatment, e.g., gene therapy or perhaps blockage of the signal pathway.
